mercaptoethanol has been researched along with mesna in 224 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 204 (91.07) | 18.7374 |
1990's | 18 (8.04) | 18.2507 |
2000's | 1 (0.45) | 29.6817 |
2010's | 1 (0.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balch, WE; Wolfe, RS | 3 |
Kell, DB; Morris, JG | 1 |
Dirkx, J; Michel, A | 1 |
Gobert, JG; Risack, LE; Vandevelde, ME | 1 |
Gunsalus, RP; Romesser, JA; Wolfe, RS | 1 |
Clarke, SW; Lopez-Vidriero, MT; Pavia, D; Thomson, ML | 1 |
Brock, N; Pohl, J; Stekar, J | 2 |
Brock, N; Burkert, H; Günther, U; Hoefer-Janker, H; Klein, HO; Mitrenga, D; Scheef, W; Schnitker, J; Voigtmann, R | 1 |
Burkert, H; Fichtner, E; Schnitker, J | 1 |
Kyncl, V; Mega, J; Pokorný, J; Skondia, V | 1 |
Fournier, AM; Timon-David, P; Vanelle, P | 1 |
Marti, C; Steiner, R; Viollier, AF | 1 |
Gunsalus, RP; Wolfe, RS | 2 |
Grate, JH; Katz, RN; Schrauzer, GN | 1 |
Adriaensen, H; Lauwers, P; Van De Walle, J | 1 |
Fahey, RC; Michael, BD; Vojnovic, B | 1 |
Liehr, JG; Roy, D | 1 |
Antman, KH; Begg, CB; Eder, JP; Elias, AD; Frei, E; Shea, T | 1 |
Goren, MP; Pratt, CB | 2 |
Fujiwara, F; Imashuku, S; Iwasaku-Fujimoto, M; Morioka, Y; Todo, S | 1 |
Dana, WJ; Schoenike, SE | 1 |
Araujo, CE; Brosto, M; Cervellino, JC; Pirisi, C; Rossi, R; Sanchez, O | 1 |
Aalders, JG; de Vries, EG; Neijt, JP; ten Bokkel Huinink, WW; vd Burg, ME; vd Gaast, A; Willemse, PH | 1 |
Berman, ML; Blessing, JA; Homesley, HD; Photopulos, G; Sutton, GP | 2 |
Beauduin, M; Closon, MT; Focan, C; Majois, F; Michel, J; Paridaens, R; Piccart, M; Salamon, E; Tueni, E; Vindevoghel, A | 1 |
Milla, A; Sanchiz, F | 1 |
Csako, G | 2 |
Dorr, RT | 1 |
Batz, M; Engel, J; Hägele, G; Niemeyer, U; Peters, R | 1 |
Lähdetie, J; Räty, R; Sorsa, M | 1 |
Einhorn, LH; Loehrer, PJ; Munshi, N; Williams, SD | 1 |
Dhingra, HM; Glisson, BS; Holoye, PY; Hong, WK; Jeffries, D; Lee, JS; Levy, JK; Murphy, WK; Raber, MN; Umsawasdi, T | 1 |
Bertram, B; Eisenbarth, J; Rajca, A; Wiessler, M | 1 |
Antman, KH; Elias, A; Grier, HE; Ryan, L; Sherman, D | 1 |
Boossy, J; Claessens, JJ; Focan, C; Focan-Henrard, D; Reginster, M | 1 |
Douglass, EC; Etcubanas, E; Goren, MP; Green, AA; Hayes, FA; Horowitz, ME; Meyer, WH; Pratt, CB; Thompson, EI; Wilimas, JA | 1 |
de Jong, PE; Elema, JD; Mulder, NH; Willemse, PH | 1 |
de Vries, EG; Willemse, PH | 1 |
Aas, P; Shaw, IC | 1 |
Exner, U; Göbel, U; Jürgens, H; Kühl, J; Ritter, J; Treuner, J; Weinel, P; Winkler, K | 1 |
Damen, WG; Keltjens, JT; Kraft, HJ; van der Drift, C; Vogels, GD | 1 |
Falkson, CI; Falkson, G; Falkson, HC | 1 |
Dybas, M; Konisky, J | 1 |
Bobik, TA; Wolfe, RS | 2 |
Berman, ML; Blessing, JA; Homesley, HD; Malfetano, J; Sutton, GP | 1 |
Brunner, KW; Cerny, T; Küpfer, A; Roth, B | 1 |
Cronin, SM; Garrick, CL; Sensenbrenner, LL | 1 |
Dodge, RK; Goren, MP; Meyer, WH; Pratt, CB; Viar, MJ; Wright, RK | 1 |
Blaut, M; Deppenmeier, U; Gottschalk, G | 1 |
Dorr, RT; Lagel, K | 1 |
Blum, A; Heyman, A | 1 |
Castel, V; Esquembre, C; Fernandez, JM; Ferris, J; Ruiz, JG; Verdeguer, A | 1 |
Blaut, M; Gottschalk, G; Peinemann, S | 1 |
Keltjens, JT; Mooijaart, RJ; van der Drift, C; van Erp, R; Vogels, GD | 1 |
Blackledge, G; Blake, AE; Blake, DR; Honigsberger, L; Latief, TN; Meanwell, CA; Mould, JJ; Shaw, IC; Spooner, D; Williams, AC | 1 |
Cantwell, BM; Harris, AL | 1 |
Goos, M; Lang, E | 1 |
Blackledge, G; Kelly, KA; Meanwell, CA | 1 |
Harrop, JS; Hill, PG | 1 |
Blackledge, G; Constantine, G; Meanwell, C | 1 |
Goren, MP; Horowitz, ME; Pratt, CB; Wright, RK | 1 |
Plowman, PN; Trott, K | 1 |
Perren, TJ; Smith, IE; Turner, RC | 1 |
Searle, AJ; Shaw, IC | 1 |
McCallum, AK | 1 |
Husband, DJ; Watkin, SW | 1 |
Brock, N; Dietrich, I; Hilgard, P; Manz, I; Niemeyer, U; Pohl, J; Przybylski, M | 1 |
Al-Safi, SA; Maddocks, JL | 1 |
Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Palangie, T; Pouillart, P; Scholl, S | 1 |
Konisky, J; Santoro, N | 1 |
Bozzino, JM; Cantwell, BM; Harris, AL | 1 |
Erexson, GL; Kligerman, AD; Wilmer, JL | 1 |
Finn, GP; Shaw, IC; Sidau, B | 1 |
Hales, BF; Slott, VL | 1 |
Ankel-Fuchs, D; Thauer, RK | 1 |
Cantwell, BM; Harris, AL; Pooley, J | 1 |
Graham, MI; Jones, MS; Shaw, IC | 1 |
Allan, SG; Hay, FG; Leonard, RC; Smyth, JF; Wolf, CR | 1 |
Kohl, M; Reuther, H; Wildenauer, DB | 1 |
Eguchi, K; Jett, JR; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suemasu, K; Tamura, T | 1 |
Blackwell, BA; Mahadevan, S; Sauer, FD | 1 |
Shaw, IC; Weeks, MS | 2 |
Cavalletti, E; Tofanetti, O; Zunino, F | 1 |
Carreras, E; Gardella, S; Grañena, A; Marín, P; Montserrat, E; Rozman, C | 1 |
Chin, T; Haas, A; Stiehm, ER | 1 |
Noll, KM; Wolfe, RS | 2 |
Berger, MR; Schmähl, D | 1 |
Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA | 1 |
Deboben, A; Frosch, PJ; Hunstein, W; Weickel, R | 1 |
James, CA; Rogers, HJ | 1 |
Bansal, SK; Bernacki, RJ; Gurtoo, HL | 1 |
Christian, E; Coerper, C; Dias Wickramanayake, P; Klein, HO | 1 |
Dijkman, JH; Kramps, JA; Stolk, J | 1 |
Ankel-Fuchs, D; Böcher, R; Noll, KM; Thauer, RK; Wolfe, RS | 1 |
Schwieder, G; Wagner, T; Zink, M | 1 |
Donnelly, MI; Hartzell, PL; Wolfe, RS | 1 |
Andriole, GL; Arasi, V; Linehan, M; Magrath, IT; Miser, JS; Sandlund, JT | 1 |
Alfredsson, H; Malmborg, AS; Strandvik, B | 1 |
Brock, N; Pohl, J | 2 |
Brock, N; Oberdorf, E; Pohl, J; Themann, H | 1 |
James, CA; Mant, TG; Rogers, HJ | 1 |
Ben Yehuda, A; Heyman, A; Steiner-Salz, D | 1 |
Ellermann, J; Kobelt, A; Pfaltz, A; Thauer, RK | 1 |
Akatchereian, C; Flamant, F; Ghosn, M; Salloum, E; Taleb, N | 1 |
Dietzsch, HJ; Pilz, U; Wichmann, G | 1 |
Grahame, DA; Stadtman, TC | 1 |
De Forges, A; Droz, JP; Ghosn, M; Theodore, C | 1 |
Graham, MI; Shaw, IC | 1 |
Begley, TP; Honek, JF; Orme-Johnson, WH; Wackett, LP; Wallace, V; Walsh, CT | 1 |
Alpi, G; Cassanelli, A; Di Silverio, F; Fini, D; Gallucci, M; Molinari, C; Ricciuti, GP | 1 |
Bobik, TA; Noll, KM; Olson, KD; Wolfe, RS | 1 |
Bast, A; Haenen, GR; Savenije-Chapel, EM | 1 |
Cantwell, BM; Carmichael, J; Ghani, S; Harris, AL | 1 |
Shaw, IC | 1 |
Ivankovic, S; Kempf, SR | 1 |
Fahey, RC; Gonick, G; Newton, GL; Ward, JF; Zheng, S | 1 |
Bos, RP; Niemeyer, U; Pool, BL; Schmähl, D; Theuws, JL | 1 |
Alberts, AS; Falkson, G; Van Zyl, L | 1 |
Anderson, J; Case, DC; Ervin, TJ; Gottlieb, A | 1 |
Carde, P; Droz, JP; Flamant, F; Friedman, S; Ghosn, M; Hayat, M; Leclerq, B | 1 |
Bogliolo, G; Lerza, R; Mencoboni, M; Pannacciulli, I; Saviane, A | 1 |
Brock, N; Guan, ZZ; He, YJ; Li, GC; Li, JQ | 1 |
Bohlmann, G; Kreft, B; Schwieder, G; Wagner, T | 1 |
Abbruzzese, JL; Ajani, JA; Boman, BM; Faintuch, JS; Goudeau, P; Levin, B; Nicaise, C; Yeomans, AC | 1 |
Luce, JK; Simons, JA | 1 |
Brade, WP; Dittrich, C; Herold, C; Keller, A; Mader, R; Moser, K; Schlappack, O; Steger, GG | 1 |
Cain, AM; Meyer, WH; Pratt, CB; Sandlund, JT | 1 |
Berti, T; D'Ancona, S; Magnolfi Zipoli, G | 1 |
Grossmann, V; Stĕtinová, V | 1 |
Czarnomska, A; Czyzewska-Szafran, H; Danysz, A; Jastrzebski, Z | 1 |
Gilles, HH; Hüster, R; Thauer, RK | 1 |
Ehrlich, RM; Goldsobel, AB; Mendoza, GR; Stiehm, ER | 1 |
Jones, MS; Murrell, RD; Shaw, IC | 1 |
Konrádová, V; Sulová, J; Vávrová, V | 1 |
Krzycki, JA; Lehman, LJ; Zeikus, JG | 1 |
Jinks, S; Millar, BC; Millar, JL; Siddik, ZH | 1 |
Ivankovic, S; Kempf, SR; Schmähl, D; Wiessler, M | 1 |
Amano, T; Ikeuchi, I | 1 |
Miranda, DR; Stoutenbeek, CP; Zandstra, DF | 1 |
Bryant, BM; Ford, HT; Jarman, M; Smith, IE | 1 |
Dalton, JI; Gordon-Smith, EC; Hows, JM; Ward, L; Woods, K | 1 |
Earl, LK; Harper, PG; McClean, AE; Mruzek, MN; Shaw, IC; Souhami, RL | 1 |
Rose, JW; Shaw, IC | 1 |
Adams, P; Bradford, E; Haines-Nutt, RP; Jakobson, K; Rowland, CG | 1 |
Ahmedzai, S; Banham, S; Burnett, A; Cunningham, D; Dorward, A; Lucie, N; Soukop, M; Stack, B; Stevenson, R; Tansey, P | 1 |
Smith, MR | 1 |
Brock, N; Låstbom, T; Ormstad, K; Orrenius, S; Pohl, J; Stekar, J; Uehara, N | 1 |
Habs, MR; Schmähl, D | 2 |
Araujo, CE; Tessler, J | 1 |
Nagle, DP; Wolfe, RS | 1 |
Becher, R; Gibas, Z; Kakati, S; Sandberg, AA | 1 |
Brock, N; Engelhardt, W; Köhnecke, B; Kunze, E; Pohl, J | 1 |
Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U | 1 |
Harper, PG; Kaye, SB; Stuart-Harris, R; Wiltshaw, E | 1 |
de Kraker, J; Voûte, PA | 1 |
Brock, N; Christian, E; Coerper, C; Klein, HO; Pohl, J; Wickramanayake, PD | 1 |
Burkert, H | 1 |
Ball, L; Blacklock, H; Knight, C; Prentice, G; Schey, S | 1 |
Gordon-Smith, EC; Hows, J; Mehta, A | 1 |
Clutterbuck, R; Jinks, S; Millar, BC; Millar, JL | 1 |
Christian, E; Coerper, C; Graf, L; Klein, HO; Wickramanayake, PD | 1 |
Bremer, K; Niederle, N; Scheulen, ME; Schütte, J; Seeber, S | 1 |
Gowing, NF; Harper, PG; Kaye, SB; Mooney, CA; Parsons, CA; Stuart-Harris, RC; Wiltshaw, E | 1 |
Heaf, DP; Matthew, DJ; Webb, GJ | 1 |
Habs, M; Schmähl, D; Tacchi, AM | 2 |
Calman, KC; Dalton, JF; Kaye, SB; Sangster, G | 1 |
Ehrlich, RM; Freedman, A; Goldsobel, AB; Stiehm, ER | 1 |
Brock, N; Engelhardt, W; Köhnecke, B; Kunze, E; Pohl, J; Steinröder, H | 1 |
Ohno, Y; Ormstad, K | 1 |
Ehrlich, RM; Freedman, A; Ljung, BM | 1 |
Ferry, JG; Greening, RC; Lovley, DR | 1 |
Gordon, MY; Gordon-Smith, EC; Hows, JM; Mehta, A; Perez, R; Ward, L; Woods, K | 1 |
Burkert, H; Hilgard, P | 1 |
Henry, RL; Taylor, GW; Washnock, MA | 1 |
Ferry, JG; Lovley, DR; White, RH | 1 |
Shaw, IC; Sidau, B | 1 |
Breuel, HP; Burkert, H; Lücker, PW; Wetzelsberger, N | 1 |
Shapiro, S; Wolfe, RS | 1 |
Ingram, D; Matthew, DJ; Preece, MA; Weller, PH | 1 |
Balch, WE; Romesser, JA | 1 |
Kedar, A; Moore, R; Murphy, GP; Simpson, CL; Tritsch, G; Williams, P | 1 |
Brock, N | 1 |
Hermans, JM; Hutten, TJ; van der Drift, C; Vogels, GD | 1 |
Bagot, C; Chouckroun, J; Devaux, C | 1 |
De Jong, MH; Hutten, TJ; Peeters, BP; van der Drift, C; Vogels, GD | 1 |
Gołabek, W; Horoch, A; Kupisz, K; Kłos, A; Semczuk, B; Siwiec, H | 1 |
Aarsen, G; Cats, BP; de Bree, PK; Duran, M; Fokkens, RH; Nibbering, NM; Wadman, SK | 1 |
Baresi, L; Wolfe, RS | 1 |
Bárdosi, L; Horváth, A; Kenyeres, P; Tekeres, M | 1 |
Czownicki, Z; Utracka-Hutka, B | 1 |
Ehrhart, H; Hartenstein, R; Misera, C; Possinger, K | 1 |
Brock, N; Pohl, J; Schneider, B; Wetzelsberger, K | 1 |
Romesser, JA; Wolfe, RS | 2 |
Link, H; Neef, V; Niethammer, D; Wilms, K | 1 |
Brock, N; Stekar, J | 1 |
Berrigan, MJ; Gurtoo, HL; Marinello, AJ; Pavelic, Z; Struck, RF; Williams, CJ | 1 |
Becher, R; Kakati, S; Sandberg, AA | 1 |
Apostolides, Z; Potgieter, DJ; Vermeulen, NM | 1 |
Caerteling, CG; Keltjens, JT; van Kooten, AM; Vogels, GD; Whitman, WB; Wolfe, RS | 1 |
Falkson, G; Falkson, HC; Stapelberg, R; Van Dyk, JJ | 1 |
Schnitker, J | 1 |
Ormstad, K; Uehara, N | 1 |
Brock, N; Pohl, J; Scheef, W; Stekar, J | 1 |
Ellsworth, H; Ensign, SA; Krum, JG; Rich, G; Sargeant, RR | 1 |
Hutchison, JE; Richman, E; Tanguay, RL; Tilton, SC; Truong, L; Waters, KM; Zaikova, T | 1 |
3 review(s) available for mercaptoethanol and mesna
Article | Year |
---|---|
Ifosfamide and mesna.
Topics: Animals; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1990 |
Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Humans; Ifosfamide; Lung Neoplasms; Mercaptoethanol; Mesna; Mitomycins | 1990 |
Mesna--a short review.
Topics: Cystitis; Expectorants; Humans; Mercaptoethanol; Mesna; Neoplasms | 1987 |
18 trial(s) available for mercaptoethanol and mesna
Article | Year |
---|---|
The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis.
Topics: Aerosols; Bronchitis; Chronic Disease; Expectorants; Female; Humans; Hypertonic Solutions; Lung; Mercaptoethanol; Mesna; Middle Aged; Radionuclide Imaging; Respiratory Function Tests; Rheology; Sodium Chloride | 1979 |
Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.
Topics: Clinical Trials as Topic; Cystitis; Drug Therapy, Combination; Hematuria; Humans; Male; Mercaptoethanol; Mesna; Neoplasms; Phosphoramide Mustards; Urologic Diseases | 1979 |
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Female; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1989 |
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
Topics: Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Mercaptoethanol; Mesna; Multicenter Studies as Topic; Ovarian Neoplasms; Platelet Count | 1989 |
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Mercaptoethanol; Mesna | 1986 |
The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
Topics: Adult; Aged; Clinical Trials as Topic; Cystitis; Female; Hemorrhage; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Random Allocation | 1986 |
Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
Topics: Administration, Oral; Adult; Female; Humans; Injections, Intravenous; Kinetics; Male; Mercaptoethanol; Mesna; Middle Aged | 1987 |
Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Pancreatic Neoplasms | 1988 |
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Humans; Ifosfamide; Kinetics; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Phosphoramide Mustards; Urinary Bladder | 1980 |
Mesna and false-positive results in ward testing for urinary ketones.
Topics: Clinical Trials as Topic; False Positive Reactions; Humans; Ketones; Mercaptoethanol; Mesna; Random Allocation | 1982 |
Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combination; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Urinary Bladder Diseases | 1983 |
Clinical overview of mesna.
Topics: Clinical Trials as Topic; Cyclophosphamide; Drug Interactions; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1983 |
Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Cystitis; Diuresis; Graft Rejection; Hematuria; Hemorrhage; Humans; Leukocyte Count; Mercaptoethanol; Mesna; Postoperative Complications; Prospective Studies | 1984 |
Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
Topics: Adolescent; Aerosols; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Female; Humans; Lung; Male; Mercaptoethanol; Mesna; Respiratory Therapy; Saline Solution, Hypertonic; Sputum | 1980 |
[Assessment of the clinical usefulness of the preparation Mesna (Mucofluid, Mistabron) produced by UCB in treatment of certain laryngological diseases (author's transl)].
Topics: Acute Disease; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Humans; Laryngectomy; Male; Mercaptoethanol; Mesna; Middle Aged; Rhinitis, Atrophic; Sinusitis | 1980 |
Clinical studies on the mucolytic effect of mesna.
Topics: Aerosols; Clinical Trials as Topic; Expectorants; Humans; Lidocaine; Lung Diseases; Mercaptoethanol; Mesna; Postoperative Complications; Thoracic Injuries | 1981 |
[Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
Topics: Clinical Trials as Topic; Cyclophosphamide; Cystitis; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1981 |
[Uroprotection with mesna in the chemotherapy of malignant tumors with oxazaphosphorines. Biometric evaluation of a sequential clinical study].
Topics: Hematuria; Humans; Mercaptoethanol; Mesna; Phosphoramide Mustards; Urologic Diseases | 1982 |
203 other study(ies) available for mercaptoethanol and mesna
Article | Year |
---|---|
Transport of coenzyme M (2-mercaptoethanesulfonic acid) in Methanobacterium ruminantium.
Topics: Biological Transport, Active; Carbon Dioxide; Euryarchaeota; Hydrogen; Hydrogen-Ion Concentration; Kinetics; Mercaptoethanol; Mesna; Oxygen; Temperature | 1979 |
Oxidation-reduction properties of coenzyme M (2-mercaptoethane sulphonate) at the mercury electrode.
Topics: Electrodes; Hydrogen-Ion Concentration; Kinetics; Mercaptoethanol; Mercury; Mesna; Oxidation-Reduction; Polarography | 1979 |
[Quantitative determination of the tryptophan residues modified by 2-hydroxy-5-nitrobenzyl bromide by mercaptoethane sulfonic acid hydrolysis. Application to diphtheria toxin].
Topics: 2-Hydroxy-5-nitrobenzyl Bromide; Diphtheria Toxin; Hydrolysis; Mercaptoethanol; Mesna; Nitrophenols; Tryptophan | 1976 |
Effect of thiol derivatives on mixed mucus and blood clots in vitro.
Topics: Acetylcysteine; Blood Coagulation; Dithiothreitol; Expectorants; Humans; In Vitro Techniques; Mercaptoethanol; Mesna; Mucus; Respiratory System; Saline Solution, Hypertonic | 1978 |
Preparation of coenzyme M analogues and their activity in the methyl coenzyme M reductase system of Methanobacterium thermoautotrophicum.
Topics: Bacteria; Mercaptoethanol; Mesna; Methane; Oxidoreductases; Substrate Specificity | 1978 |
Specificity and biological distribution of coenzyme M (2-mercaptoethanesulfonic acid).
Topics: Bacteria; Eukaryota; Euryarchaeota; Fungi; Kidney; Mercaptoethanol; Mesna; Plants; Structure-Activity Relationship | 1979 |
[Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].
Topics: Animals; Antidotes; Carcinosarcoma; Cyclophosphamide; Ifosfamide; Mercaptoethanol; Mesna; Phosphoramide Mustards; Rats; Urine | 1979 |
[Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
Topics: Adolescent; Adult; Aged; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Gastrointestinal Diseases; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms; Phosphoramide Mustards; Testicular Neoplasms | 1979 |
The role of mesna in the treatment of status asthmaticus in children.
Topics: Adolescent; Adult; Asthma; Bronchi; Child; Child, Preschool; Humans; Infant; Mercaptoethanol; Mesna; Therapeutic Irrigation | 1979 |
[Double contrast studies of the colon. Use of acetyl-cystein or mucofluid? (author's transl)].
Topics: Acetylcysteine; Colon; Contrast Media; Costs and Cost Analysis; Humans; Mercaptoethanol; Mesna; Radiography | 1979 |
[High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].
Topics: Adult; Cyclophosphamide; Cystitis; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Osteosarcoma | 1979 |
Stimulation of CO2 reduction to methane by methylcoenzyme M in extracts Methanobacterium.
Topics: Adenosine Triphosphate; Bacteria; Carbon Dioxide; Cell-Free System; Magnesium; Mercaptoethanol; Mesna; Methane; Oxidation-Reduction; Structure-Activity Relationship | 1977 |
Coenzyme M and methylcobalamin in methane biosynthesis: results of model studies.
Topics: Bacteria; Mercaptoethanol; Mesna; Methane; Methylation; Oxidation-Reduction; Oximes; Structure-Activity Relationship; Vitamin B 12 | 1978 |
New approach to the cultivation of methanogenic bacteria: 2-mercaptoethanesulfonic acid (HS-CoM)-dependent growth of Methanobacterium ruminantium in a pressureized atmosphere.
Topics: Anaerobiosis; Bacteria; Bacteriological Techniques; Carbon Dioxide; Hydrogen; Mercaptoethanol; Mesna; Methane; Pressure | 1976 |
Mistabron in the intensive care unit.
Topics: Humans; Intensive Care Units; Lung Diseases; Mercaptoethanol; Mesna | 1976 |
The effects of counter-ion condensation and co-ion depletion upon the rates of chemical repair of poly(U) radicals by thiols.
Topics: Cysteamine; Cysteine; Electric Conductivity; Electrons; Glutathione; In Vitro Techniques; Ions; Mercaptoethanol; Mercaptoethylamines; Mesna; Particle Accelerators; Poly U; Pulse Radiolysis; Radiation-Protective Agents; Sulfhydryl Compounds | 1991 |
Inhibition of estrogen-induced kidney carcinogenesis in Syrian hamsters by modulators of estrogen metabolism.
Topics: Animals; Antioxidants; Azoles; Butylated Hydroxyanisole; Cricetinae; Dicumarol; Estradiol; Glutathione Peroxidase; Isoindoles; Kidney Neoplasms; Male; Mercaptoethanol; Mesna; Mesocricetus; NADPH-Ferrihemoprotein Reductase; Organoselenium Compounds; Quinone Reductases; Quinones; Selenium | 1990 |
High-dose ifosfamide with mesna uroprotection: a phase I study.
Topics: Blood; Bone Marrow; Central Nervous System; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Humans; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Neoplasms; Remission Induction; Time Factors; Urinary Tract | 1990 |
False-positive ketone tests: a bedside measure of urinary mesna.
Topics: Adolescent; Child; False Positive Reactions; Female; Humans; Ifosfamide; Ketones; Mercaptoethanol; Mesna | 1990 |
[Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
Topics: Bone Neoplasms; Child; Cyclophosphamide; Cystitis; Female; Hematuria; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptoethanol; Mesna; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhabdomyosarcoma | 1990 |
Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Uterine Cervical Neoplasms | 1990 |
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1990 |
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
Topics: Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms; Sarcoma; Uterine Cervical Neoplasms | 1990 |
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1990 |
High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1990 |
Causes, consequences, and recognition of false-positive reactions for ketones.
Topics: Acetaminophen; Adolescent; False Positive Reactions; Female; Humans; Ketones; Mercaptoethanol; Mesna; Sulfhydryl Compounds | 1990 |
Nuclear magnetic resonance spectra and molecular structure of mesna.
Topics: Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Models, Chemical; Molecular Structure | 1990 |
Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.
Topics: Animals; Bone Marrow; Cyclophosphamide; Drug Interactions; Erythrocytes; Male; Mercaptoethanol; Mesna; Micronucleus Tests; Mutagenicity Tests; Rats; Salmonella typhimurium; Urinary Tract | 1990 |
Cyclophosphamide and ifosfamide: role of uroprotective agents.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Urogenital Neoplasms | 1990 |
Ifosfamide with mesna uroprotection in the management of lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Survival Rate; Urologic Diseases; Vincristine | 1990 |
New mixed disulfides of L-cysteine derivatives and of glutathione with diethyldithiocarbamic acid and 2-mercaptoethanesulfonic acid.
Topics: Antineoplastic Agents; Chemical Phenomena; Chemistry; Cysteine; Disulfides; Ditiocarb; Glutathione; Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Molecular Structure | 1990 |
Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged | 1989 |
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
Topics: Adolescent; Child; Child, Preschool; Drug Evaluation; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna; Neoplasms; Remission Induction; Sarcoma | 1989 |
Severe renal failure following high-dose ifosfamide and mesna.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms | 1989 |
Mesna: continuous or bolus infusion?
Topics: Drug Administration Schedule; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Mercaptoethanol; Mesna; Sarcoma; Soft Tissue Neoplasms | 1989 |
In vitro inhibition of brain glutamic acid decarboxylase by sodium 2-mercaptoethanesulphonate and endogenous thiols and its possible in vivo consequences.
Topics: Animals; Blood-Brain Barrier; Brain; Cysteine; Glutamate Decarboxylase; Glutathione; In Vitro Techniques; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1989 |
High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1989 |
Stimulation of the methylcoenzyme M reduction by uridine-5'-diphospho-sugars in cell-free extracts of Methanobacterium thermoautotrophicum (strain delta H).
Topics: Adenosine Triphosphate; Cell-Free System; Chromatography, High Pressure Liquid; Euryarchaeota; Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Oxidation-Reduction; Oxidoreductases; Spectrophotometry, Ultraviolet; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate Sugars | 1989 |
Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Urologic Diseases | 1989 |
Transport of coenzyme M (2-mercaptoethanesulfonic acid) and methylcoenzyme M [(2-methylthio)ethanesulfonic acid] in Methanococcus voltae: identification of specific and general uptake systems.
Topics: Anaerobiosis; Biological Transport; Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Radioisotope Dilution Technique; Sulfur Radioisotopes; Tritium | 1989 |
An unusual thiol-driven fumarate reductase in Methanobacterium with the production of the heterodisulfide of coenzyme M and N-(7-mercaptoheptanoyl)threonine-O3-phosphate.
Topics: Disulfides; Electron Transport; Electrophoresis, Polyacrylamide Gel; Euryarchaeota; Fumarates; Furans; Mercaptoethanol; Mesna; Oxidation-Reduction; Phosphothreonine; Substrate Specificity; Succinate Dehydrogenase; Succinates; Succinic Acid; Sulfhydryl Compounds | 1989 |
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration].
Topics: Biological Availability; Humans; Inactivation, Metabolic; Infusions, Intravenous; Infusions, Parenteral; Injections, Subcutaneous; Male; Mercaptoethanol; Mesna; Middle Aged | 1989 |
Effect of mesna on cyclophosphamide.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cystitis; Drug Interactions; Humans; Immunosuppression Therapy; Mercaptoethanol; Mesna | 1989 |
Mesna excretion and ifosfamide nephrotoxicity in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercaptoethanol; Mesna; Neoplasms; Proteinuria | 1989 |
Dependence on membrane components of methanogenesis from methyl-CoM with formaldehyde or molecular hydrogen as electron donors.
Topics: Cell Wall; Electron Transport; Euryarchaeota; Formaldehyde; Hydrogen; Mercaptoethanol; Mesna; Methane | 1989 |
Interaction between cisplatin and mesna in mice.
Topics: Animals; Cisplatin; Drug Interactions; Leukemia P388; Male; Mercaptoethanol; Mesna; Mice; Mice, Nude | 1989 |
[MESNA--an uroprotective agent].
Topics: Humans; Mercaptoethanol; Mesna | 1989 |
Fatal encephalopathy with ifosfamide/mesna.
Topics: Brain Diseases; Child; Drug Therapy, Combination; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Rhabdomyosarcoma | 1989 |
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1989 |
Ifosfamide and mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cystitis; Hemorrhage; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1989 |
ATP synthesis coupled to methane formation from methyl-CoM and H2 catalyzed by vesicles of the methanogenic bacterial strain Gö1.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; ATP Synthetase Complexes; Euryarchaeota; Hydrogen-Ion Concentration; Mercaptoethanol; Mesna; Methane; Multienzyme Complexes; Nitriles; Phosphates; Phosphotransferases | 1989 |
Inorganic pyrophosphate synthesis during methanogenesis from methylcoenzyme M by cell-free extracts of Methanobacterium thermoautotrophicum (strain delta H).
Topics: Adenosine Triphosphatases; Cell-Free System; Diphosphates; Energy Metabolism; Euryarchaeota; Mercaptoethanol; Mesna; Methane; Salicylanilides | 1988 |
Encephalopathy associated with ifosphamide/mesna therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Uterine Neoplasms | 1985 |
Ifosfamide/mesa and encephalopathy.
Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma | 1985 |
Ifosfamide, mesna, and encephalopathy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Cyclophosphamide; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna | 1985 |
Hypersensitivity to mesna.
Topics: Adult; Drug Hypersensitivity; Female; Humans; Intradermal Tests; Mercaptoethanol; Mesna | 1985 |
Avoiding ifosfamide/mesna encephalopathy.
Topics: Adolescent; Adult; Aged; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Probability | 1986 |
Ifosfamide/mesna nomogram and serum albumin.
Topics: Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Pelvic Inflammatory Disease; Serum Albumin | 1986 |
Ifosfamide/mesna nomogram and serum albumin.
Topics: Humans; Ifosfamide; Mercaptoethanol; Mesna; Methods; Serum Albumin | 1986 |
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; CD13 Antigens; Child; Child, Preschool; Creatinine; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Kidney Tubules; Male; Mercaptoethanol; Mesna; Proteinuria | 1987 |
Mesna and total body irradiation.
Topics: Bone Marrow Transplantation; Humans; Leukemia; Mercaptoethanol; Mesna; Premedication; Radiation-Protective Agents; Whole-Body Irradiation | 1987 |
Encephalopathy with rapid infusion ifosfamide/mesna.
Topics: Brain Diseases; Drug Therapy, Combination; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethanol; Mesna | 1987 |
Mesna and total body irradiation.
Topics: Animals; Mercaptoethanol; Mesna; Radiation Injuries, Experimental; Radiation-Protective Agents; Whole-Body Irradiation | 1987 |
Ifosfamide/mesna encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epilepsy, Tonic-Clonic; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Psychoses, Substance-Induced | 1987 |
Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
Topics: Drug Therapy, Combination; Humans; Hypokalemia; Ifosfamide; Male; Mercaptoethanol; Mesna | 1988 |
Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.
Topics: Acrolein; Animals; Cyclophosphamide; Ifosfamide; Kinetics; Mass Spectrometry; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains | 1985 |
Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.
Topics: Azathioprine; Chromatography, Thin Layer; Cyclophosphamide; Humans; In Vitro Techniques; Lymphocyte Culture Test, Mixed; Mercaptoethanol; Mesna | 1986 |
[Encephalopathy caused by an ifosfamide-mesna combination].
Topics: Adult; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1988 |
Characterization of bromoethanesulfonate-resistant mutants of Methanococcus voltae: evidence of a coenzyme M transport system.
Topics: Alkanesulfonates; Alkanesulfonic Acids; Amino Acids; Biological Transport; Drug Resistance, Microbial; Ethylmaleimide; Euryarchaeota; Mercaptoethanol; Mesna; Mutation; Oxidoreductases; Species Specificity | 1987 |
Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
Topics: Acrolein; Cell Cycle; Cells, Cultured; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Mercaptoethanol; Mesna; Mitotic Index; Mutagenicity Tests; Phosphoramide Mustards; Sister Chromatid Exchange; T-Lymphocytes | 1986 |
Protecting the bladder from cyclophosphamide with mesna.
Topics: Cyclophosphamide; Humans; Mercaptoethanol; Mesna; Sulfhydryl Compounds; Urinary Bladder | 1986 |
Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.
Topics: Animals; Body Weight; Bone and Bones; Cyclophosphamide; Drug Interactions; Female; Fetus; Mercaptoethanol; Mesna; Pregnancy; Rats; Rats, Inbred Strains; Teratogens | 1986 |
Methane formation from methyl-coenzyme M in a system containing methyl-coenzyme M reductase, component B and reduced cobalamin.
Topics: Catalysis; Dithiothreitol; Euryarchaeota; Mercaptoethanol; Mesna; Methane; Oxidoreductases; Vitamin B 12 | 1986 |
False-positive ketonuria during ifosfamide and mesna therapy.
Topics: False Positive Reactions; Female; Humans; Ifosfamide; Ketone Bodies; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged | 1986 |
The fate of [14C]-mesna in the rat.
Topics: Animals; Carbon Radioisotopes; Immunoglobulins; Kidney; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Serum Albumin; Tissue Distribution | 1986 |
Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum.
Topics: Animals; Cell Cycle; Cisplatin; Disaccharidases; Drug Administration Schedule; Intestinal Mucosa; Leukemia L1210; Male; Mercaptoethanol; Mesna; Mice; Microscopy, Electron, Scanning | 1986 |
The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
Topics: Erythrocytes; Humans; In Vitro Techniques; Ion Exchange; Kinetics; Mercaptoethanol; Mesna; Sulfates; Sulfur Radioisotopes | 1986 |
The role of tetrahydromethanopterin and cytoplasmic cofactor in methane synthesis.
Topics: Cell Membrane; Chromatography, Ion Exchange; Euryarchaeota; Kinetics; Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Methane; Pterins; Spectrophotometry, Ultraviolet; Surface-Active Agents | 1986 |
Interaction between mesna and selected transition metals in vitro and in vivo.
Topics: Albumins; Animals; Copper; In Vitro Techniques; Lead; Male; Mercaptoethanol; Mesna; Metals; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Tissue Distribution | 1986 |
Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
Topics: Animals; Cyclophosphamide; Glutathione; Male; Mercaptoethanol; Mesna; Mice; Urinary Bladder | 1986 |
[Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclophosphamide; Cystitis; Fluid Therapy; Furosemide; Hemorrhage; Humans; Leukemia; Mercaptoethanol; Mesna; Postoperative Complications | 1986 |
Cyclophosphamide-induced water intoxication: treatment with fluid restriction and 2-mercaptoethane sulfonate.
Topics: Child; Cyclophosphamide; Humans; Male; Mercaptoethanol; Mesna; Water Intoxication; Water-Electrolyte Balance | 1986 |
Component C of the methylcoenzyme M methylreductase system contains bound 7-mercaptoheptanoylthreonine phosphate (HS-HTP).
Topics: Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Euryarchaeota; Hot Temperature; Mercaptoethanol; Mesna; Multienzyme Complexes; Oxidoreductases; Protein Denaturation | 1986 |
Delayed development of bladder cancer in male SD rats induced with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine following concomitant administration of sodium 2-mercaptoethane sulfonate.
Topics: Animals; Butylhydroxybutylnitrosamine; Male; Mercaptoethanol; Mesna; Neoplasm Metastasis; Rats; Urinary Bladder Neoplasms | 1986 |
Prediction of ifosfamide/mesna associated encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Soft Tissue Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1986 |
[Delayed allergy following mesna].
Topics: Adult; Humans; Hypersensitivity, Delayed; Lymphocyte Activation; Male; Mercaptoethanol; Mesna | 1986 |
Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection.
Topics: Chromatography, High Pressure Liquid; Electrochemistry; Half-Life; Humans; Mercaptoethanol; Mesna | 1986 |
Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Female; Leukemia, Experimental; Lung Neoplasms; Melanoma, Experimental; Mercaptoethanol; Mesna; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma, Experimental | 1987 |
False-positive results for ketone with the drug mesna and other free-sulfhydryl compounds.
Topics: False Positive Reactions; Humans; Hydrogen-Ion Concentration; Ketones; Kinetics; Mercaptoethanol; Mercaptopurine; Mesna; Nitroprusside; Reagent Kits, Diagnostic; Reagent Strips; Sulfhydryl Compounds | 1987 |
Recent experience with ifosfamide/mesna in solid tumors. International satellite symposium to the 3rd European Conference on Clinical Oncology. Stockholm, June 1985. Proceedings.
Topics: Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1986 |
Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
Topics: Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Mercaptoethanol; Mesna; Middle Aged; Osteosarcoma; Soft Tissue Neoplasms | 1986 |
In vitro effect of a mucolytic thiol agent on the activity of polymorphonuclear leucocyte elastase and antileucoprotease.
Topics: Depression, Chemical; Humans; In Vitro Techniques; Mercaptoethanol; Mesna; Neutrophils; Pancreatic Elastase; Protease Inhibitors; Proteinase Inhibitory Proteins, Secretory; Proteins | 1986 |
7-Mercaptoheptanoylthreonine phosphate functions as component B in ATP-independent methane formation from methyl-CoM with reduced cobalamin as electron donor.
Topics: Adenosine Triphosphate; Euryarchaeota; Kinetics; Magnesium; Mercaptoethanol; Mesna; Methane; Phosphothreonine; Threonine; Vitamin B 12 | 1987 |
Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
Topics: Animals; Cyclophosphamide; Cysteine; Drug Interactions; Female; Leukemia L1210; Mercaptoethanol; Mesna; Metabolic Clearance Rate; Mice; Platelet Count; Sulfhydryl Compounds | 1987 |
Incorporation of coenzyme M into component C of methylcoenzyme M methylreductase during in vitro methanogenesis.
Topics: Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Methane; Oxidoreductases; Sulfur Radioisotopes | 1987 |
The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclophosphamide; Cystitis; Female; Hematuria; Hemorrhage; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms | 1987 |
N-acetylcysteine and 2-mercaptoethane sulphonate inhibit anti-pseudomonas activity of antibiotics in vitro.
Topics: Acetylcysteine; Anti-Bacterial Agents; Drug Interactions; Mercaptoethanol; Mesna; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1987 |
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Topics: Animals; Biotransformation; Cyclophosphamide; DNA; Glutathione; Ifosfamide; Kidney; Leukemia, Experimental; Mercaptoethanol; Mesna; Rats; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna.
Topics: Animals; Cyclophosphamide; Cystitis; Cytoplasm; Epithelium; Male; Mercaptoethanol; Mesna; Microscopy, Electron, Scanning; Muscle, Smooth; Necrosis; Rats; Rats, Inbred Strains; Urinary Bladder | 1987 |
The role of 7-mercaptoheptanoylthreonine phosphate in the methylcoenzyme M methylreductase system from Methanobacterium thermoautotrophicum.
Topics: Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Methane; Oxidoreductases; Phosphothreonine; Threonine | 1987 |
False positive reaction for urinary ketones with mesna.
Topics: Adult; False Positive Reactions; Humans; Ketones; Leukemia, Myeloid, Acute; Mercaptoethanol; Mesna | 1987 |
On the role of N-7-mercaptoheptanoyl-O-phospho-L-threonine (component B) in the enzymatic reduction of methyl-coenzyme M to methane.
Topics: Chromatography, Gas; Euryarchaeota; Mercaptoethanol; Mesna; Methane; Oxidoreductases; Phosphothreonine; Threonine | 1987 |
Irreversible encephalopathy with ifosfamide/mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Maxillary Neoplasms; Mercaptoethanol; Mesna; Rhabdomyosarcoma; Vincristine | 1987 |
[Effect of mucolytic agents on various antibiotics].
Topics: Acetylcysteine; Anti-Bacterial Agents; Child; Dose-Response Relationship, Drug; Humans; Mercaptoethanol; Mesna; Pseudomonas aeruginosa | 1987 |
In vitro methane and methyl coenzyme M formation from acetate: evidence that acetyl-CoA is the required intermediate activated form of acetate.
Topics: Acetates; Acetyl Coenzyme A; Coenzyme A; Euryarchaeota; Mercaptoethanol; Mesna; Methane | 1987 |
Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Disulfides; Female; Humans; Male; Mercaptoethanol; Mesna; Sulfhydryl Compounds | 1987 |
Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged | 1987 |
Ifosfamide/mesna and hematuria.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hematuria; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna | 1987 |
Substrate analogues as mechanistic probes of methyl-S-coenzyme M reductase.
Topics: Euryarchaeota; Indicators and Reagents; Kinetics; Mercaptoethanol; Mesna; Oxidoreductases; Substrate Specificity | 1987 |
Mercaptoethane sulphonate in cystinic calculosis therapy.
Topics: Cystinuria; Female; Humans; Male; Mercaptoethanol; Mesna; Urinary Calculi | 1987 |
Evidence that the heterodisulfide of coenzyme M and 7-mercaptoheptanoylthreonine phosphate is a product of the methylreductase reaction in Methanobacterium.
Topics: Euryarchaeota; Mercaptoethanol; Mesna; Methane; Oxidation-Reduction; Phosphothreonine; Sulfides; Threonine | 1987 |
Physiological importance of the heterodisulfide of coenzyme M and 7-mercaptoheptanoylthreonine phosphate in the reduction of carbon dioxide to methane in Methanobacterium.
Topics: Carbon Dioxide; Coenzymes; Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Methane; Phosphothreonine; Threonine | 1988 |
Inhibition of rat hepatic microsomal lipid peroxidation by mesna via glutathione.
Topics: Animals; Ascorbic Acid; Depression, Chemical; Glutathione; In Vitro Techniques; Lipid Peroxides; Male; Mercaptoethanol; Mesna; Microsomes, Liver; Rats; Rats, Inbred Strains | 1987 |
A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Doxorubicin; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1988 |
Mesna and oxazaphosphorine cancer chemotherapy.
Topics: Chemical Phenomena; Chemistry; Cyclophosphamide; Cystitis; Humans; Mercaptoethanol; Mesna; Tissue Distribution | 1987 |
Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.
Topics: Animals; Cisplatin; Kidney Diseases; Kidney Neoplasms; Mercaptoethanol; Mesna; Rats | 1987 |
Radioprotection of DNA by thiols: relationship between the net charge on a thiol and its ability to protect DNA.
Topics: Anions; Cations; Cysteamine; Dithiothreitol; DNA; DNA Damage; Glutathione; Mercaptoethanol; Mercaptoethylamines; Mesna; Radiation-Protective Agents; Sulfhydryl Compounds; Thiomalates | 1988 |
In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity.
Topics: Acrolein; Animals; Antineoplastic Agents; Biotransformation; Cyclophosphamide; Male; Mercaptoethanol; Mesna; Mutagens; Rats; Rats, Inbred Strains | 1988 |
Malignant pleural mesothelioma: phase II pilot study of ifosfamide and mesna.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercaptoethanol; Mesna; Mesothelioma; Middle Aged; Pleural Neoplasms | 1988 |
Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Evaluation; Hematologic Diseases; Hematuria; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mercaptoethanol; Mesna; Middle Aged | 1988 |
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Topics: Adolescent; Brain Diseases; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Phenobarbital | 1988 |
Studies on hemotoxicity of cyclophosphamide, doxorubicin and cis-diamminodichloroplatinum combined with sodium-2-mercaptoethane sulfonate.
Topics: Animals; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cells; Male; Mercaptoethanol; Mesna; Mice; Mice, Inbred DBA; Premedication | 1988 |
Ifosfamide and Mesna in advanced malignancies.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms | 1988 |
Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.
Topics: Animals; Cisplatin; Female; Fosfomycin; Kidney; Lethal Dose 50; Mercaptoethanol; Mesna; Mice; Mice, Inbred DBA; Thiosulfates | 1988 |
Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
Topics: Adolescent; Adult; Child; Cyclophosphamide; Cystitis; Cystoscopy; Female; Hematuria; Humans; Male; Mercaptoethanol; Mesna; Prospective Studies; Rhabdomyosarcoma; Sarcoma | 1988 |
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1988 |
Mesna-induced urticaria.
Topics: Adolescent; Adult; Child; Humans; Male; Mercaptoethanol; Mesna; Urticaria | 1988 |
Arginine 2-mercaptoethane sulfonate and sodium 2-mercaptoethane sulfonate: a comparative study of their effects upon tumour cells.
Topics: Animals; Antineoplastic Agents; Arginine; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Male; Melanoma, Experimental; Mercaptoethanol; Mesna; Mice; Tumor Cells, Cultured | 1988 |
[The effect of Prehepon (sodium 2-mercaptoethanesulfonate) on reproduction in rats].
Topics: Animals; Female; Fertility; Fetus; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Reproduction | 1988 |
The effect of sodium-2-mercaptoethane-sulphonate, N-acetylcysteine and cysteine on the uptake of cytosine arabinoside by normal and neoplastic thymus cells of mice.
Topics: Acetylcysteine; Animals; Cells, Cultured; Cysteine; Cytarabine; Female; Male; Mercaptoethanol; Mesna; Mice; Thymus Gland; Thymus Neoplasms; Tumor Cells, Cultured | 1988 |
Is coenzyme M bound to factor F430 in methanogenic bacteria? Experiments with Methanobrevibacter ruminantium.
Topics: Binding Sites; Chemical Phenomena; Chemistry; Chromatography, Gel; Chromatography, Ion Exchange; Euryarchaeota; Mercaptoethanol; Mesna; Metalloporphyrins; Metalloproteins; Nickel; Oxidoreductases; Temperature | 1985 |
Bone marrow transplantation for Wiskott-Aldrich syndrome: report of 2 cases with use of 2-mercaptoethane sulfonate.
Topics: Bone Marrow Transplantation; Child; Cyclophosphamide; Cystitis; Humans; Infant; Male; Mercaptoethanol; Mesna; Wiskott-Aldrich Syndrome | 1985 |
Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.
Topics: Administration, Oral; Adult; Cysteine; Disulfides; Humans; Male; Mercaptoethanol; Mesna; Sulfhydryl Compounds; Urinary Bladder Diseases | 1985 |
Comparison of the effect of three oral mucolytics on the ultrastructure of the tracheal epithelium in rabbits.
Topics: Acetylcysteine; Administration, Oral; Animals; Carbocysteine; Epithelium; Expectorants; Mercaptoethanol; Mesna; Rabbits; Time Factors; Trachea | 1985 |
Acetate catabolism by Methanosarcina barkeri: evidence for involvement of carbon monoxide dehydrogenase, methyl coenzyme M, and methylreductase.
Topics: Acetates; Acetic Acid; Adenosine Triphosphate; Aldehyde Oxidoreductases; Antigen-Antibody Complex; Carbon Radioisotopes; Euryarchaeota; Immune Sera; Kinetics; Mercaptoethanol; Mesna; Methane; Multienzyme Complexes; Oxidoreductases | 1985 |
Mesna does not reduce cisplatin induced nephrotoxicity in the rat.
Topics: Animals; Cell Line; Cell Survival; Cisplatin; Cricetinae; Cricetulus; Drug Interactions; Kidney; Kinetics; Lung; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains | 1985 |
Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
Topics: Animals; Cisplatin; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Mercaptoethanol; Mesna; Rats | 1985 |
Simultaneous determination of 2-mercaptoethanesulfonate and its disulfide in human urine by isotachophoresis.
Topics: Electrophoresis; Humans; Mercaptoethanol; Mesna | 1985 |
Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients.
Topics: Aerosols; Airway Resistance; Albuterol; Bronchodilator Agents; Expectorants; Humans; Mercaptoethanol; Mesna; Postoperative Care; Respiration, Artificial | 1985 |
Mesnum and cyclophosphamide cystitis.
Topics: Adult; Cyclophosphamide; Cystitis; Humans; Leukemia, Myeloid, Acute; Male; Mercaptoethanol; Mesna | 1980 |
Difference in bioactivity between two preparations of cyclophosphamide.
Topics: Animals; Bronchial Neoplasms; Cyclophosphamide; Humans; Mass Spectrometry; Mercaptoethanol; Mesna; Rats | 1983 |
Infusion of ifosphamide plus mesna.
Topics: Cyclophosphamide; Drug Interactions; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mesna; Urinary Bladder Neoplasms | 1984 |
Infusion of ifosfamide plus mesna.
Topics: Cyclophosphamide; Drug Combinations; Drug Stability; Drug Storage; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mesna | 1984 |
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesna.
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged | 1983 |
Reversal of 2-bromoethanesulfonate inhibition of methanogenesis in Methanosarcina sp.
Topics: Alkanesulfonates; Alkanesulfonic Acids; Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Methanol; Methyltransferases; Oxidoreductases; Structure-Activity Relationship | 1983 |
Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
Topics: Animals; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Kinetics; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1983 |
Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Male; Mercaptoethanol; Mesna; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Risk; Urinary Bladder Neoplasms | 1983 |
Component A of the methyl coenzyme M methylreductase system of Methanobacterium: resolution into four components.
Topics: Bacterial Proteins; Euryarchaeota; Flavin-Adenine Dinucleotide; Macromolecular Substances; Mercaptoethanol; Mesna; Oxidoreductases | 1983 |
Cytogenetic testing of mutagenic and radioprotective effects of mesna.
Topics: Chromosome Aberrations; Crossing Over, Genetic; Drug Evaluation, Preclinical; Gamma Rays; Humans; In Vitro Techniques; Leukemia; Lymphocyte Activation; Lymphocytes; Mercaptoethanol; Mesna; Radiation-Protective Agents; Sister Chromatid Exchange | 1983 |
[Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
Topics: Animals; Autoradiography; Cyclophosphamide; Female; Mercaptoethanol; Mesna; Mucous Membrane; Rats; Rats, Inbred Strains; Thymidine; Urinary Bladder; Urinary Bladder Diseases | 1983 |
Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
Topics: Animals; Cyclophosphamide; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1983 |
Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mercaptoethanol; Mesna | 1983 |
High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1983 |
Ifosfamide, mesna and vincristine in paediatric oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna; Neoplasms; Vincristine | 1983 |
High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.
Topics: Cyclophosphamide; Drug Evaluation; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1983 |
The development of mesna for regional detoxification.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cystitis; Humans; Inactivation, Metabolic; Kidney; Mercaptoethanol; Mesna; Nitrogen Mustard Compounds; Urinary Bladder | 1983 |
Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia.
Topics: Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cystitis; Female; Hemorrhage; Humans; Leukemia; Male; Mercaptoethanol; Mesna | 1983 |
Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data).
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cystitis; Diuresis; Hemorrhage; Humans; Mercaptoethanol; Mesna | 1983 |
Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
Topics: Animals; Cyclophosphamide; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1983 |
Studies on the toxicity of cyclophosphamide in combination with mesna in vitro and in vivo.
Topics: Animals; Cricetinae; Cricetulus; Cyclophosphamide; Cysteine; Drug Therapy, Combination; Female; Humans; Male; Mercaptoethanol; Mesna; Mice; Mice, Inbred C57BL | 1983 |
Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.
Topics: Animals; Cyclophosphamide; Drug Therapy, Combination; Ifosfamide; Male; Mercaptoethanol; Mesna; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1983 |
Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
Topics: Cyclophosphamide; Drug Evaluation; Drug Interactions; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms; Testicular Neoplasms; Urinary Tract | 1983 |
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Kidney; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1983 |
In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis.
Topics: Azlocillin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Mercaptoethanol; Mesna; Penicillins; Pseudomonas Infections | 1983 |
Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna).
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Drinking; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Nitrosamines; Rats; Rats, Inbred Strains; Time Factors; Urinary Bladder Neoplasms | 1984 |
Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
Topics: Adult; Cyclophosphamide; Fanconi Syndrome; Female; Humans; Ifosfamide; Intestinal Neoplasms; Leiomyosarcoma; Mercaptoethanol; Mesna | 1984 |
The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
Topics: Bone Marrow Transplantation; Child; Cyclophosphamide; Cystitis; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Infant; Male; Mercaptoethanol; Mesna | 1984 |
Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
Topics: Animals; Autoradiography; Cell Division; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Epithelium; Female; Kinetics; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Time Factors; Urinary Bladder | 1984 |
N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
Topics: Acetylcysteine; Animals; Intestinal Mucosa; Kidney; Kinetics; Liver; Lung; Male; Mercaptoethanol; Mesna; Myocardium; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Tissue Distribution | 1984 |
Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
Topics: Animals; Cyclophosphamide; Cystitis; Drug Evaluation, Preclinical; Edema; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Ulcer; Urinary Bladder; Urinary Bladder Diseases | 1984 |
Rapidly growing rumen methanogenic organism that synthesizes coenzyme M and has a high affinity for formate.
Topics: Animals; Cattle; Culture Media; Enzyme Induction; Euryarchaeota; Formates; Hydrogen; Male; Mercaptoethanol; Mesna; Rumen; Substrate Specificity | 1984 |
Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
Topics: Cyclophosphamide; Humans; Ifosfamide; Infusions, Parenteral; Kidney Diseases; Mercaptoethanol; Mesna | 1984 |
Mistabron effects on platelets and blood coagulation.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Humans; Mercaptoethanol; Mesna; Platelet Aggregation; Rats | 1984 |
Identification of methyl coenzyme M as an intermediate in methanogenesis from acetate in Methanosarcina spp.
Topics: Acetates; Deuterium; Euryarchaeota; Gas Chromatography-Mass Spectrometry; Mercaptoethanol; Mesna; Methane; Methylation | 1984 |
[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
Topics: Animals; Carcinoma, Transitional Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Male; Mercaptoethanol; Mesna; Papilloma; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1984 |
Determination of sodium 2-mercaptoethanesulphonate by high-performance liquid chromatography using post-column reaction colorimetry or electrochemical detection.
Topics: Chromatography, High Pressure Liquid; Colorimetry; Electrochemistry; Humans; Mercaptoethanol; Mesna | 1984 |
Bioavailability of orally administered mesna.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Biological Availability; Cyclophosphamide; Humans; Ifosfamide; Injections, Intravenous; Male; Mercaptoethanol; Mesna | 1984 |
Methyl-coenzyme M, an intermediate in methanogenic dissimilation of C1 compounds by Methanosarcina barkeri.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Cell-Free System; Chelating Agents; Euryarchaeota; Mercaptoethanol; Mesna; Methane; Methanol; Methylamines; Methyltransferases | 1980 |
Methyl coenzyme M reductase from Methanobacterium thermoautotrophicum. Resolution and properties of the components.
Topics: Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Oxidoreductases; Species Specificity | 1980 |
Coenzyme M: preparation and assay.
Topics: Archaeal Proteins; Biological Assay; Euryarchaeota; Indicators and Reagents; Mercaptoethanol; Mesna; Methods; Methyltransferases; Oxidoreductases | 1980 |
The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
Topics: Animals; Cyclophosphamide; Injections, Intravenous; Mercaptoethanol; Mesna; Organ Size; Rats; Urinary Bladder | 1980 |
The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cystitis; Erythrocyte Count; Ifosfamide; Mercaptoethanol; Mesna; Rats; Urologic Diseases | 1980 |
Analysis of coenzyme m (2-mercaptoethanesulfonic acid) derivatives by isotachophoresis.
Topics: Electrophoresis; Mercaptoethanol; Mesna | 1980 |
Action of a mucolytic in the first 72 hours after abdominal surgery. Concerning 34 patients with respiratory insufficiency.
Topics: Abdomen; Adult; Aged; Blood Gas Analysis; Blood Pressure; Cardiac Output; Chronic Disease; Expectorants; Female; Humans; Male; Mercaptoethanol; Mesna; Middle Aged; Oxygen; Postoperative Care; Pulmonary Diffusing Capacity; Respiratory Insufficiency; Risk | 1980 |
Coenzyme M derivatives and their effects on methane formation from carbon dioxide and methanol by cell extracts of Methanosarcina barkeri.
Topics: Carbon Dioxide; Euryarchaeota; Hydrogen; Mercaptoethanol; Mesna; Methane; Methanol | 1981 |
2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency.
Topics: Amino Acids; Cysteine; Humans; Infant, Newborn; Kidney; Liver; Mercaptoethanol; Mesna; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Seizures; Sulfites | 1981 |
Levels of coenzyme F420, coenzyme M, hydrogenase, and methylcoenzyme M methylreductase in acetate-grown Methanosarcina.
Topics: Acetates; Coenzymes; Culture Media; Euryarchaeota; Hydrogen; Hydrogenase; Mercaptoethanol; Mesna; Oxidoreductases; Riboflavin | 1981 |
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
Topics: Animals; Cyclophosphamide; Cystitis; Female; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Rats; Urinary Bladder | 1981 |
[Prevention of urotoxic complications during therapy with cytostatics. The problem of the interaction between sodium-II-mercaptoethanesulfonate and cyclophosphamide].
Topics: Animals; Carcinoma 256, Walker; Cyclophosphamide; Cystitis; DNA; Mercaptoethanol; Mesna; Rats | 1981 |
[Pharmacokinetics of Uromitexan].
Topics: Biotransformation; Humans; Kinetics; Mercaptoethanol; Mesna | 1981 |
Interaction of coenzyme M and formaldehyde in methanogenesis.
Topics: Adenosine Triphosphate; Euryarchaeota; Formaldehyde; Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Methane; Oxidation-Reduction | 1981 |
Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cystitis; Humans; Mercaptoethanol; Mesna | 1981 |
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
Topics: Animals; Cyclophosphamide; Ifosfamide; Kidney Diseases; Mercaptoethanol; Mesna; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1982 |
Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
Topics: Acetylcysteine; Aminopyrine N-Demethylase; Animals; Aryl Hydrocarbon Hydroxylases; Cyclophosphamide; Cytochrome P-450 Enzyme System; Leukopenia; Liver; Male; Mercaptoethanol; Mesna; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Oxidoreductases; Rats; Rats, Inbred Strains; Urinary Bladder | 1982 |
Mesna and bone-marrow transplantation.
Topics: Bone Marrow Transplantation; Humans; Mercaptoethanol; Mesna; Transplantation, Isogeneic | 1982 |
Coupling of methyl coenzyme M reduction with carbon dioxide activation in extracts of Methanobacterium thermoautotrophicum.
Topics: Carbon Dioxide; Euryarchaeota; Kinetics; Mercaptoethanol; Mesna; Oxidation-Reduction; Species Specificity | 1982 |
High-performance liquid chromatography of some coenzyme M (2-mercaptoethanesulphonic acid) derivatives by ion pairing on reversed-phase columns.
Topics: Chromatography, High Pressure Liquid; Euryarchaeota; Mercaptoethanol; Mesna | 1982 |
Presence of coenzyme M derivatives in the prosthetic group (coenzyme MF430) of methylcoenzyme M reductase from Methanobacterium thermoautotrophicum.
Topics: Chemical Phenomena; Chemistry; Euryarchaeota; Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Metalloporphyrins; Metalloproteins; Nickel; Oxidoreductases | 1982 |
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.
Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Urinary Bladder Diseases | 1982 |
Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (dimesna) in the rat.
Topics: Animals; Biological Transport; Glutathione; Kidney; Kinetics; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1982 |
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
Topics: Animals; Cyclophosphamide; Dogs; Drug Interactions; Female; Ifosfamide; Kinetics; Lethal Dose 50; Male; Mercaptoethanol; Mesna; Mice; Neoplasms, Experimental; Proscillaridin; Rats; Urinary Bladder Diseases | 1982 |
Kinetic and microcalorimetric analysis of substrate and cofactor interactions in epoxyalkane:CoM transferase, a zinc-dependent epoxidase.
Topics: Alkylation; Amino Acid Substitution; Calorimetry; Carbon-Sulfur Lyases; Cations, Divalent; Chlorides; DNA Primers; Epoxide Hydrolases; Hydrogen-Ion Concentration; Kinetics; Mercaptoethanol; Mesna; Mutagenesis, Site-Directed; Protein Binding; Recombinant Proteins; Substrate Specificity; Xanthobacter; Zinc; Zinc Compounds | 2002 |
Surface functionalities of gold nanoparticles impact embryonic gene expression responses.
Topics: Animals; Embryo, Nonmammalian; Gene Expression Profiling; Gene Expression Regulation, Developmental; Gene Regulatory Networks; Gold; Mass Spectrometry; Mercaptoethanol; Mesna; Metal Nanoparticles; Particle Size; Quaternary Ammonium Compounds; Sulfhydryl Compounds; Surface Properties; Time Factors; Zebrafish | 2013 |